Massachusetts scientist among 12 honored by American Stroke Association

NEW ORLEANS — Twelve scientists leading the way in stroke research have been recognized for their exceptional achievements during the American Stroke Association’s International Stroke Conference 2022.

The group includes Julie A. DiCarlo, a researcher from Massachusetts General Hospital, who has been awarded the Stroke Rehabilitation Award. The award encourages investigators to undertake or continue research and/or clinical work in the field of stroke rehabilitation.

DiCarlo is lab manager for the Laboratory for Translational Neurorecovery and Senior Clinical Research Coordinator in the Center for Neurotechnology and Neurorecovery at Mass General. She presented her winning study, “Patient-reported And Performance-based Outcomes Separate Independently and Are Associated with Distinct Patterns of Neuroanatomical Injury After Stroke,” at the conference on Wednesday morning.

DiCarlo’s research uses metrics to compare how doctors rate their patients’ health with how patients rate their own health. The assessments to not always match, said DiCarlo.

“This is important to consider when choosing which outcomes to use when assessing patients’ during care planning or during stroke clinical trials,” she said.

DiCarlo was honored as part of an illustrious group that included four, groundbreaking scientists who have devoted their careers to stroke research, seven authors of notable new research and one scientist recognized for outstanding mentorship. To see the complete list of honorees, click here.

The American Stroke Association’s International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2022 was held in person in New Orleans and virtually, Feb. 8-11.

The three-day conference featured more than 1,500 compelling presentations in 17 categories that emphasized basic, clinical and translational sciences as research evolves toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies.